In late 2023 the FDA placed BPC-157 on the 503A bulks list "Category 2," which limits compounding pharmacy access
For more detail on mechanism of action, signaling pathways, and controlled experimental applications, researchers can review the peer-reviewed literature below: Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications: Storage, Handling & Stability Guidelines Use the applicable lot/source record for storage of unopened material
L.et al (2004a)
Talk with a healthcare professional if there are concerns about vitamin B12 levels
CJC-1295 (Mod GRF 1-29) is a synthetic analog of a naturally-occurring peptide hormone, somatocrinin
Experimental investigations have reported effects on VEGFR2 phosphorylation, focal adhesion kinase (FAK) activation, ERK1/2 signaling, and nitric oxide-associated regulatory pathways